Sri LankaSri Lanka's universal healthcare system and rising middle class create compelling demand for innovative life-sciences products. Taevas delivers end-to-end NMRA regulatory support, distributor access, and commercial execution so you reach revenue faster.
Select an industry to see regulatory pathways, services, and how Taevas supports your Sri Lanka market entry.
National Medicines Regulatory Authority of Sri Lanka (NMRA)
Sri Lanka's medical device market is expanding rapidly, driven by public hospital modernisation programmes and growing private healthcare investment. The NMRA regulates all medical devices under a risk-based classification system (Class A to D), requiring product registration and import licences before market entry. Taevas manages the full regulatory lifecycle, from dossier preparation through post-market surveillance, ensuring your device reaches Sri Lankan clinicians without delay.
All medical devices must be registered with the NMRA prior to import or sale. Class A devices follow a streamlined notification pathway, while Class C and D devices require full technical dossier review.
A valid NMRA import licence is required for every consignment of medical devices entering Sri Lanka. Taevas prepares and submits the licence application and manages renewal cycles on your behalf.
Foreign manufacturers must appoint a Sri Lanka-based Authorised Representative who is accountable to the NMRA for regulatory compliance, adverse event reporting, and recall coordination.
Registered devices are subject to ongoing NMRA post-market surveillance requirements including adverse event reporting, periodic safety updates, and field safety corrective action notifications.
Taevas combines deep NMRA regulatory expertise with on-the-ground commercial networks to give life-sciences brands the fastest, lowest-risk path to revenue in Sri Lanka.
Our Sri Lanka team has direct experience navigating NMRA submissions across medical devices, pharmaceuticals, cosmetics, and food supplements, minimising approval delays and regulatory rejections.
Taevas maintains active relationships with distributors, pharmacies, and healthcare institutions across all nine provinces of Sri Lanka, ensuring your product reaches every relevant channel.
Our pre-built regulatory templates, established NMRA relationships, and parallel-track submission process consistently reduce time to first commercial sale compared to self-managed market entry.
We have vetted and active partnerships with leading Sri Lanka pharmaceutical distributors, medical device dealers, and FMCG channel partners, enabling rapid commercial activation without the risk of selecting the wrong partner.
Taevas maintains relationships with influential Sri Lankan clinicians, hospital procurement decision-makers, and professional society leaders who can accelerate product adoption in both public and private healthcare settings.
Taevas has successfully supported multiple international life-sciences brands in obtaining NMRA approvals and achieving commercial traction in Sri Lanka, with a track record of on-time submissions and zero major compliance incidents.
Speak with a Taevas Sri Lanka specialist today to map your regulatory pathway, identify the right distribution partners, and build a clear timeline to first revenue.